310 related articles for article (PubMed ID: 25165876)
1. Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2.
Bertsch U; Röder C; Kalthoff H; Trauzold A
Cell Death Dis; 2014 Aug; 5(8):e1390. PubMed ID: 25165876
[TBL] [Abstract][Full Text] [Related]
2. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
[TBL] [Abstract][Full Text] [Related]
3. Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells.
Willms A; Schittek H; Rahn S; Sosna J; Mert U; Adam D; Trauzold A
PLoS One; 2019; 14(4):e0214847. PubMed ID: 30947287
[TBL] [Abstract][Full Text] [Related]
4. DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer.
Yu R; Albarenque SM; Cool RH; Quax WJ; Mohr A; Zwacka RM
Cancer Biol Ther; 2014; 15(12):1658-66. PubMed ID: 25482930
[TBL] [Abstract][Full Text] [Related]
5. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
[TBL] [Abstract][Full Text] [Related]
6. TRAIL receptor signaling and therapeutics.
Abdulghani J; El-Deiry WS
Expert Opin Ther Targets; 2010 Oct; 14(10):1091-108. PubMed ID: 20819019
[TBL] [Abstract][Full Text] [Related]
7. TRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells.
Szliszka E; Mazur B; Zydowicz G; Czuba ZP; Król W
Folia Histochem Cytobiol; 2009; 47(4):579-85. PubMed ID: 20430723
[TBL] [Abstract][Full Text] [Related]
8. Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer.
Pennarun B; Meijer A; de Vries EG; Kleibeuker JH; Kruyt F; de Jong S
Biochim Biophys Acta; 2010 Apr; 1805(2):123-40. PubMed ID: 19961901
[TBL] [Abstract][Full Text] [Related]
9. Regulation of TNF-Related Apoptosis-Inducing Ligand Signaling by Glycosylation.
Micheau O
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29498673
[TBL] [Abstract][Full Text] [Related]
10. Importin β1 protein-mediated nuclear localization of death receptor 5 (DR5) limits DR5/tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced cell death of human tumor cells.
Kojima Y; Nakayama M; Nishina T; Nakano H; Koyanagi M; Takeda K; Okumura K; Yagita H
J Biol Chem; 2011 Dec; 286(50):43383-93. PubMed ID: 22020938
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) induces apoptosis in primary renal cell carcinoma cells in vitro and inhibits tumor growth in vivo.
Zeng Y; Wu XX; Fiscella M; Shimada O; Humphreys R; Albert V; Kakehi Y
Int J Oncol; 2006 Feb; 28(2):421-30. PubMed ID: 16391797
[TBL] [Abstract][Full Text] [Related]
12. Translating TRAIL-receptor targeting agents to the clinic.
den Hollander MW; Gietema JA; de Jong S; Walenkamp AM; Reyners AK; Oldenhuis CN; de Vries EG
Cancer Lett; 2013 May; 332(2):194-201. PubMed ID: 22531313
[TBL] [Abstract][Full Text] [Related]
13. TRAIL-receptor 2-a novel negative regulator of p53.
Willms A; Schupp H; Poelker M; Adawy A; Debus JF; Hartwig T; Krichel T; Fritsch J; Singh S; Walczak H; von Karstedt S; Schäfer H; Trauzold A
Cell Death Dis; 2021 Jul; 12(8):757. PubMed ID: 34333527
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells.
Bremer E; de Bruyn M; Samplonius DF; Bijma T; ten Cate B; de Leij LF; Helfrich W
J Mol Med (Berl); 2008 Aug; 86(8):909-24. PubMed ID: 18504532
[TBL] [Abstract][Full Text] [Related]
15. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.
Walczak H; Degli-Esposti MA; Johnson RS; Smolak PJ; Waugh JY; Boiani N; Timour MS; Gerhart MJ; Schooley KA; Smith CA; Goodwin RG; Rauch CT
EMBO J; 1997 Sep; 16(17):5386-97. PubMed ID: 9311998
[TBL] [Abstract][Full Text] [Related]
16. Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer.
Mert U; Sanlioglu AD
Cell Mol Life Sci; 2017 Jan; 74(2):245-255. PubMed ID: 27510421
[TBL] [Abstract][Full Text] [Related]
17. TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2.
Natoni A; MacFarlane M; Inoue S; Walewska R; Majid A; Knee D; Stover DR; Dyer MJ; Cohen GM
Br J Haematol; 2007 Nov; 139(4):568-77. PubMed ID: 17922877
[TBL] [Abstract][Full Text] [Related]
18. TRAIL Induces Nuclear Translocation and Chromatin Localization of TRAIL Death Receptors.
Mert U; Adawy A; Scharff E; Teichmann P; Willms A; Haselmann V; Colmorgen C; Lemke J; von Karstedt S; Fritsch J; Trauzold A
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31416165
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.
Harper N; Hughes MA; Farrow SN; Cohen GM; MacFarlane M
J Biol Chem; 2003 Nov; 278(45):44338-47. PubMed ID: 12920112
[TBL] [Abstract][Full Text] [Related]
20. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
